|
|
|
MONDAY, JULY 8, 2002 |
| POSTER
SESSION: HOMOCYSTEINE |
HYPERHOMOCYSTEINEMIA
IS INDEPENDENT RISK FACTOR IHD IN RUSSIAN POPULATION
Y.V. Tcherkas, A.D. Denisenko, Russia |
A
NEW ULTRARAPID CAPILLARY ELECTROPHORESIS METHOD FOR TOTAL
PLASMA HOMOCYSTEINE MEASUREMENT
A. Zinellu, F. Galistu, M.F. Usai, L. Deiana, G.M.
Pes, C. Carru, Italy |
IDENTIFICATION
OF PHOSPHOPROTEINS FROM HOMOCYSTEINE STIMULATED HUMAN
VASCULAR ENDOTHELIAL CELLS
C. Mayrhofer, G. Allmaier, G. Sunder-Plassmann,
O. Wagner, R. Sunder-Plassmann, Austria |
PARADOXICAL
ANTIOXIDANT EFFECT OF HOMOCYSTEINE IN PATIENTS WITH CLASSIC
CARDIOVASCULAR RISK FACTORS
A. Bajo-Martinez, E. Bernal, M. Calbacho, A. Ugalde-Canitrot,
O. Sanchez, J.F. Martin-Lazaro,
C. Santiuste, R. Fabregate, J. Saban, Spain |
ASSOCIATION
BETWEEN SERUM HOMOCYSTEINE AND CORONARY HEART DISEASE
IN A FINNISH HIGH-RISK MALE POPULATION
G. Alfthan, P. Jousilahti, J.T. Salonen, J. Tuomilehto,
Finland |
BLOOD
LIPOPROTEINS, ANTIOXIDANT ENZYMES AND HOMOCYSTEINE IN
HEALTHY MIDDLE-AGED WOMEN ACCORDING THE MENOPAUSAL STATUS
G.L. Bosilkova, S.A. Dzhekova-Stojkova, M.A. Krstevska,
Macedonia |
ROLE
OF HYPERHOMOCYSTEINEMIA IN ATHEROTHROMBOTIC STROKE
N. Degirmenci, B. Ince, G. Hergenc, Turkey |
HYPERHOMOCYSTINAEMIA
MAY ACCOUNT FOR THE EXCESS CHD RISK IN UK INDIAN ASIANS
COMPARED WITH EUROPEAN WHITES
J. Hooper, M. Kemp, J. Donovan, J. Chambers, UK
|
CARBOHYDRATE
- DEFICIENT TRANSFERRIN AND HOMOCYSTEINE IN PATIENTS WITH
MIXED HYPERLIPIDEMIA
J. Dvorakova, L. Dubska, J. Hyanek, L. Taborsky,
Czech Republic |
HOMOCYSTEINE
INDUCES VASCULAR EXPRESSION OF TIMP-1, PCNA AND GELATINOLYTIC
ACTIVITY IN VIVO AND IN VITRO
J.A. Rodriguez, R. Arias, M. Perez-Ilzarbe, B.
Nespereira, P. Fernandez, J.A. Paramo, Spain |
EFFECT
OF C677T METHYLENETETRAHYDROFOLATE REDUCTASE POLYMORPHISM
ON PLASMA HOMOCYSTEINE LEVELS IN ETHNIC GROUPS
K. Raslova, J. Gasparovic, Z. Basistova, M. Zacharova,
P. Blazicek, J. Lietava, D. Sivakova,
Slovak Republic |
PLASMA
TOTAL HOMOCYSTEINE AS A RISK FACTOR FOR CORONARY ARTERY
DISEASE
M. Krstevska, S. Dzhekova-Stojkova, G. Bosilkova,
Macedonia |
HOMOCYSTEINE
CONFOUNDERS IN ARTERIAL HYPERTENSION
A.N. Arapogianni, G.P. Vyssoulis, E.A. Karpanou, P.I.
Kloufetos, J.K. Rizos,
M.A. Toutouza, A.G. Marinakis, D.V. Cokkinos, P.K.
Toutouzas, Greece |
HOMOCYSTEINE
AND FOLATE LEVELS IN PATIENS WITH PROVEN CORONARY ARTERY
DISEASE
M. Gellerman, Y.G. Assaraf, A. Krivelevich, T.
Snitkovsky, N. Roguin, Israel |
PLASMA
TOTAL HOMOCYSTEINE AND MTHFR POLYMORPHISM IN YOUNG PATIENTS
WITH MYOCARDIAL INFARCTION
M.P. Simula, L. Musino, A. Zinellu, F. Galistu,
G. Congiu, R. Cabiddu, L. Dettori, G. Motta,
M.L. Stochino, A. Partenza, M. Barca, P.P. Bitti, S. Bertolini,
L. Deiana, C. Carru, G.M. Pes, Italy |
HOMOCYSTEINE
AS A RISK FACTOR OF ATHEROSCLEROTIC LESION
R.M. Santos, J.P. Freitas, M.E. Macedo, A.A. Monteiro,
M.I. Rebelo, E.M. Castro, A.S. Silva,
L. Belo, A.F. Freitas, Portugal |
PLASMA
HOMOCYSTEINE LEVELS IN RELATION TO SEVERAL CARDIOVASCULAR
RISK FACTORS: THE ATTICA STUDY
C. Chrysohoou, C. Pitsavos, J. Skoumas, D. Panagiotakos,
A. Zeimbekis, M. Toutouza,
I. Papaioannou, C. Stefanadis, P. Toutouzas, Greece |
RELATIONSHIP
BETWEEN HYPERHOMOCYSTEINAEMIA, BLOOD PRESSURE AND HEART
RATE VARIABILITY IN HAEMODIALYSED PATIENTS
L. Locsey, B. Szlanka, A. Dan, B. Borbas, Hungary
|
MTHFR
POLYMORPHISM IN PATIENTS WITH STROKE AND DEEP VENOUS THROMBOSIS
M. Cubrilo-Turek, E. Topic, A. Begonja, M. Stefanovic,
A-M. Simundic, V. Demarin, Croatia |
BLOOD
HOMOCYSTEINE AND KIDNEY INVOLVEMENT IN TYPE ONE AND TYPE
TWO DIABETES MELLITUS
O. Giampietro, D. Calvi, G. Forotti, E. Boldrini,
F. Marchini, L. Moretti, E. Matteucci, Italy |
HOMOCYSTEINE
DECREASES ENDOTHELIN-1 EXPRESSION BY INTERFERING WITH
THE AP-1 SIGNALING PATHWAY
S. Drunat, N. Moatti, J-L. Paul, K. Demuth, France |
| POSTER SESSION:
IMMUNOLOGICAL ASPECTS, PHOSPHOLIPASES |
HORMONE
REPLACEMENT THERAPY WITH TIBOLONE IS NOT ASSOCIATED WITH
ADVERSE EFFECTS ON INFLAMMATION AND TRIGLYCERIDE METABOLISM
G.W.L. Lloyd, P.J. Lumb, G. Chick, E.A. McGing,
A.F. Cooper, G. Jackson, A. Wierzbicki, UK |
THE
ROLE OF BALLOON INFLATION PRESSURE ON SYSTEMIC INFLAMMATORY
RESPONSE AFTER PERCUTANEOUS CORONARY INTERVENTION
V. Aytekin, A.B. Catakoglu, S. Aytekin, I.C.C.
Demiroglu, H.K. Askin, S. Tufekcioglu,
C. Demiroglu, Turkey |
EFFECT
OF ATORVASTATION AND FISH OIL ON PLASMA HIGH SENSITIVE
C-REACTIVE PROTEIN, INTERLEUKIN-6 AND TUMOR NECROSIS FACTOR-ALPHA
LEVELS IN OBESE SUBJECTS
D.C. Chan, G.F. Watts, P.H.R. Barrett, L.J. Beilin,
T.A. Mori, Australia |
HYPOCHOLESTEROLEMIA
DURING INFLAMMATORY DISEASE
Y. Wang, P. Fraunberger, B. Siegele, A. Heim, D.
Seidel, A.K. Walli, Germany |
CHROMATIN
IMAGE ANALYSIS IS A NEW EVIDENCE OF LYMPHOCYTES INTERESTED
IN ET-1, OTHER PROINFLAMMATORY CYTOKINES AND SCAM AT ATHEROSCLEROSIS
A.I. Teplyakov, E.V. Pryschepova, Belarus |
GLUCOSE
INHIBITS A FAT-MEDIATED POSTPRANDIAL C3 INCREASE BY IMPROVED
FREE FATTY ACID TRAPPING
A.J.H.H.M. Van Oostrom, H. Van Dijk, M. Castro
Cabezas, The Netherlands |
INTERLEUKIN-6
LEVELS AND GENOTYPES IN RELATION TO MYOCARDIAL INFARCTION;
RESULTS FROM THE SHEEP STUDY
A.M. Bennet, J. Prince, L. Lyrenes, B. Wiman, J.
Frostegard, U. De Faire, Sweden |
PROINFLAMMATORY
CYTOKINES IN ATHEROGENIC HYPERLIPIDEMIAS
B. Okopien, A. Madej, D. Belowski, J. Kowalski,
M. Zielinski, Z. Kalina, Z. Herman, Poland |
INFLAMMATION
IN ACUTE CORONARY SYNDROMES AS INDICATED BY ELEVATED CRP
LEVELS. ASSOCIATION WITH PROTEOLYTIC ENZYMES THAT DESTABILIZE
THE PLAQUE AND THEIR REGULATORS
D. Tziakas, G. Chalikias, E. Hatzinikolaou, E.
Papadopoulos, G. Trypsianis,
E. Papadopoulou, D. Floros, I. Tentes,E. Kontoleon-Bakalopoulou,
D. Hatseras, Greece |
ASSOCIATION
OF THE ANTI INFLAMMATORY ACTION OF INTERLEUKIN 10 WITH
METALLOPROTEINASES AND OTHER INFLAMMATORY MARKERS IN ACUTE
CORONARY SYNDROMES
D. Tziakas, G. Chalikias, E. Hatzinikolaou, E.
Papadopoulos, G. Trypsianis,
E. Papadopoulou, D. Floros, I. Tentes, E. Kontoleon-Bakalopoulou,
D. Hatseras, Greece |
DOES
ORAL L-ARGININE SUPPLEMENTATION INFLUENCE ON SERUM TUMOR
NECROSIS FACTOR-ALFA LEVEL IN OBESE PATIENTS WITH HYPERTENSION?
D. Pupek-Musialik, P. Bogdanski, M. Luczak, W.
Bryl, M. Cymerys, A. Jablecka, Poland |
TUMOR
NECROSIS FACTOR- ALFA - THE MISSING LINK BETWEEN OBESITY
AND INSULIN RESISTANCE?
D. Pupek-Musialik, P. Bogdanski, M. Luczak, W.
Bryl, M. Cymerys, Poland |
LOCAL
LIPID DEPOSITION IN UNINVOLVED HUMAN AORTIC INTIMA CORRELATES
WITH INFLAMMATORY CELLS' ACCUMULATION AND INFLAMMATORY
ACTIVATION OF VESSEL WALL CELLS
E.R. Andreeva, I.A. Mikhailova, A.N. Orekhov, Russia
|
INFLAMMATORY
ENDOTHELIAL CELL MARKERS AND MORBIDITY IN ELDERLY HIGH
RISK MEN
E.M. Hjerkinn, I. Seljeflot, I. Hjermann, H. Arnesen,
Norway |
THE
SERUM TRANSFORMING GROWTH FACTOR-BETA (TGF-BETA) LEVEL
IN PATIENTS WITH CORONARY HEART DISEASE
E.B. Romuk, B. Skrzep-Poloczek, C. Wojciechowska,
A.R. Tomasik, J. Szygula, E. Birkner,
J. Wodniecki, Poland |
ABSENCE
OF CMV DNA IN ENDARTERECTOMY SPECIMENS BY THE POLYMERASE
CHAIN REACTION (PCR)
G.S. Latsios, A. Saetta, N.V. Michalopoulos, G.
Fanourakis, P.S. Davaris, Greece |
BIOOPTICAL
VISUALIZIATION OF THE HEAT SHOCK RESPONSE OF HUMAN VASCULAR
ENDOTHELIAL CELLS (HUVEC) AFTER THEIR EXPOSURE TO DIFFERENT
FORMS OF STRESS
G. Pfister, B. Henderson, M. Kind, G. Wick, Austria
|
SERUM
TNF-ALPHA AND ITS SOLUBLE RECEPTORS I AND II IN THE POSTMENOPAUSAL
WOMEN (PMW) WITH A KNOWN RISK OF ATHEROMATOSIS
R. Dybkowski, J. Krzysiek, T. Milewicz, A. Janczak-Saif,
G. Krzysiek, K. Sztefko, M. Radecka,
M. Kacprzak, Poland |
MODIFIED
LIPOPROTEINS AND ACUTE PHASE REACTANTS INDUCE LIGAND SPECIFIC
CLUSTERING OF AN INNATE IMMUNITY RECEPTOR COMPLEX IN MONOCYTE
RAFTS
G. Rothe, A. Pfeiffer, M. Torzewski, A. Bottcher,
E. Orso, W. Drobnik, G. Schmitz, Germany |
LDL-INDUCED
INTERCELLULAR LIPID ACCUMULATION CAUSES OVEREXPRESSION
OF PROINFLAMMATORY CYTOKINES
I.V. Suprun, E.R. Andreeva, L.A. Medvedeva, T.A.
Scalbe, S.M. Baida, A.N. Orekhov, Russia |
ALLICOR-INDUCED
ATHEROSCLEROSIS REGRESSION IS ACCOMPANIED BY INHIBITION
OF PROINFLAMMATORY CYTOKINES EXPRESSION
I.V. Suprun, I.A. Sobenin, L.A. Medvedeva, T.A.
Scalbe, S.M. Baida, A.N. Orekhov, Russia |
SYSTEMIC
INFLAMMATION, CHLAMYDIA PNEUMONIAE DNA IN CIRCULATING
LEUKOCYTES AND CORONARY ATHEROSCLEROSIS
J.M. Bosmans, V. Hoymans, D. Ursi, F. Dubois, E.
Van Marck, M. Altwegg, M. Ieven,
C. Vrints, Switzerland |
LIPID
COMPOSITION AND LIPOPOLYSACCHARIDE BINDING CAPACITY OF
LIPOPROTEINS IN PLASMA AND LYMPH OF PATIENTS WITH THE
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME (SIRS)
J.H.M. Levels, L.C.J.M. Lemaire, A.E. Van Den Ende,
S.J.H. Van Deventer,
J.J.B. Van Lanschot, The Netherlands |
EFFECT
OF DIETARY SUPPLEMENTATION WITH N-3 POLYUNSATURATED FATTY
ACIDS ON PROINFLAMMATORY CYTOKINES IN DYSLIPIDAEMIC PATIENTS
L. Rallidis, G. Paschos, G. Liakos, A. Velissaridou,
E. Papasteriadis, A. Zampelas, Greece |
POTENTIAL
INVOLVEMENT OF SECRETORY PHOSPHOLIPASE A2 ACTIVITY IN
ATHEROSCLEROSIS. CORRELATION WITH THE DYAD CD40/CD40L
L. Fuentes, M. Sanchez-Crespo, M. Hernandez, J. Alonso,
F. Fernandez-Aviles, M.L. Nieto,
Spain |
ISCHEMIA-
AND TNF-ALPHA-INDUCED PRIMING OF BLOOD MACROPHAGES INCREASES
THEIR ABILITY TO OXIDATIVELY MODIFY CIRCULATING LDL IN
AEROBIC AND ISCHEMIC CONDITIONS
M.V. Bilenko, A.V. Khilchenko, Russia |
IMMUNOLOGICAL
AND CLASSICAL RISK FACTORS FOR ATHEROSCLEROSIS IN YOUNG
AUSTRIAN MALES
M. Knoflach, H. Perschinka, M. Kind, M. Said, R.
Sief, M. Giesinger, B. Mayrl, H. Gaston,
R. Van Der Zee, S. Kiechl, J. Willeit, G. Wick, Austria,
UK, The Netherlands |
INFLUENZA
INFECTION EXERTS PROMINENT INFLAMMATORY AND THROMBOTIC
EFFECTS ON THE ATHEROSCLEROTIC PLAQUES OF APO E-DEFICIENT
MICE
M. Madjid, S. Litovsky, A. Akhtar, P.R. Wyde, S.W.
Casscells, M. Naghavi, USA |
DETECTING
PLAQUE INFLAMMATION IN ATHEROSCLEROTIC RABBITS BY SPIO:
A NONINVASIVE METHOD FOR IMAGING MACROPHAGE INFILTRATION
IN VULNERABLE PLAQUES
M. Azadpour, S. Litovsky, M. Madjid, S.W. Casscells,
J.T. Willerson, M. Naghavi, USA |
IS
C-REACTIVE PROTEIN LEVEL A USEFUL MARKER OF SEVERITY AND
INFARCT SIZE IN PATIENTS WITH ACUTE ST ELEVATION MYOCARDIAL
INFARCTION
M. Suleiman, Y. Levy, A. Roguin, D. Aronson,M.
Halabi, A. Goldberg, A. Kerner, M. Kapeliovich,
H. Hammerman, Israel |
ROLE
OF PRO-INFLAMMATORY CYTOKINES AND ENDOTHELIAL DYSFUNCTION
IN PATIENTS WITH ANGIOGRAFICALLY PROVED CORONARY ATHEROSCLEROSIS
O.M. Korzh, Ukraine |
ASSOCIATION
OF HUMAN PAVOVIRUS 19 IN PATIENTS WITH CORONARY ARTERY
DISEASE
S-C. Liu, M-F. Yu, F-T. Chiang, M-R. Wu, K-L. Hsu,
R-B. Hsu, S-S. Wang, F-T. Chiang, Taiwan |
ASSOCIATION
OF CHLAMYDIA PNEUMONIAE WITH CORONARY ARTERY DISEASE IS
DEPENDENT ON THE MODIFYING EFFECT OF MANNOSE-BINDING LECTIN
Sz. Rugonfalvi-Kiss, V. Endresz, H.O. Madsen, K.
Burian, Z. Prohaszka, I. Karadi, L. Romics,
E. Gonczol, G. Fust, P. Garred, Hungary, Denmark |
CHYLOMICRON
REMNANTS STIMULATE INTERLEUKIN-1BETA PRODUCTION IN THP-1
MACROPHAGES
T. Okumura, Y. Fujioka, S. Tsuboi, S. Morimoto,
M. Masai, Y. Naito, D. Kawasaki,
T. Sakoda, T. Tsujino, T. Iwasaki, Japan |
UPREGULATION
OF IMMUNE SYSTEM IN FAMILIAL HYPOALPHALIPOPROTEINEMIA
F. Bigazzi, B. Dal Pino, E. Chella, M. Puntoni,
L. Ciulli, S. Lusso, G. Sassi, M. Tuoni,
T. Sampietro, A. Bionda, Italy |
RELATIONSHIP
BETWEEN INFLAMMATION IN AORTIC INTIMA AND DEVELOPMENT
OF LIPOIDOSIS
V.S. Zhdanov, I.P. Drobkova, Russia |
THE
BENEFITS FROM LEISURE TIME PHYSICAL ACTIVITY ON ANTHROPOGENIC
AND INFLAMMATORY MARKERS, IN A POPULATION-BASED RANDOM
SAMPLE OF MALES AND FEMALES: THE ATTICA STUDY
J. Skoumas, C. Pitsavos, C. Chrysohoou, D. Panagiotakos,
M. Toutouza, I. Papaioannou,
A. Zeimbekis, C. Stefanadis, P. Toutouzas, Greece |
C-REACTIVE
PROTEIN AS A LIPID-TRANSPORTING PROTEIN IN INFLAMMATION.
FUNCTIONAL LIPOIDOSIS IN RETICULOENDOTHELIAL CELLS
V.N. Titov, V.G. Tischenkov, V.V. Kukharchuk, Russia
|
PREVALENCE
OF LIBMAN-SACKS VEGETATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS
I. Moyssakis, N.J. Pantazopoulos, Y. Hallaq, M.
Tektonidou, V. Vassiliou, V. Votteas, Greece |
COMPARISON
OF CARDIAC LESIONS IN PRIMARY ANTIPHOSPHOLIPID SYNDROME
VERSUS ANTIPHOSPHOLIPID NEGATIVE SYSTEMIC LUPUS ERYTHEMATOSUS
I. Moyssakis, M. Tectonidou, P. Vlachoyannopoulos, N.J.
Pantazopoulos, Y. Hallaq,
V. Votteas, Greece |
DIETARY
COPPER DEFICIENCY DECREASES MONOCYTE EXPRESSION OF CD11B
(MAC-1) IN NORMOCHOLESTEROLAEMIC RABBITS
D.J.Lamb, G.A.A. Ferns, UK |
SEROPREVALENCE
OF ANTI CHLAMYDIA PNEMONIAE AND ANTI HELICOBACTER PYLORI
IGG ANTIBODIES IN CORONARY ARTERY DISEASE PATIENTS
R. Vijayvergiya, A. Grover, N. Agarwal, M. Sharma,
M. Singh, M. Khullar, India |
DOES
IMMUNOMODULATION OF CORONARY ATHEROSCLEROSIS HAVE THE
FUTURE?
E. Andreeva, Russia |
LONG-TERM
ENDOTHELIAL IMPACT OF CHLAMYDIA PNEUMONIAE INFECTION
D. Coca-Robinot, E. Sanchez-Largo, J. Gonzalez, A.
Ugalde-Canitrot, M. Calbacho, E. Bernal,
J. Saban, Spain |
PREVALENCE OF CHRONIC INFECTIONS IN SUBJECTS WITH HYPOALPHALIPOPROTEINEMIA
J.M. Mostaza, N. Camino, R. Pena, M. Baquero, C.
Lahoz, Spain |
C.
PNEUMONIAE ANTIBODIES BETWEEN 7 MONTHS AND 8 YEARS OF
AGE IN A PROSPECTIVE CHILD COHORT
I.K. Volanen, R.M. Vainionpää, J. Ilonen,
P.I. Markula, H.Y. Helenius, O. Simell, Finland |
METABOLISM
OF BETA2-GLYCOPROTEIN IN MICE - IMPACT OF THE ASIALOGLYCOPROTEIN
RECEPTOR
A. Hrzenjak, S. Frank, Y. Zhou, G.M. Kostner, Austria,
Israel |
CRP
AS A MARKER OF SUBCLINICAL ATHEROSCLEROSIS AND OF INSULIN
RESISTANCE IN FAMILIAL COMBINED HYPERLIPIDEMIA
H. Vaverkova, M. Halenka, D. Karasek, M. Hutyra,
D. Novotny, L. Slavik, M. Budikova,
Czech Republic |
CHANGES
IN SERUM LIPID PARAMETERS IN PATIENTS WITH ACUTE INFECTION
E. Liberopoulos, G. Pappas, G. Alexandridis, S.
Tsiara, M. Milionis, D. Christides, C. Tzalas,
E. Bairaktari, C. Seferiades, E. Tsianos, M. Elisaf, Greece |
| POSTER SESSION:
MANAGEMENT OF DIABETES AND ATHEROSCLEROSIS IN CHILDREN
|
ARTERIAL
WALL STIFFNESS IS ASSOCIATED WITH PERIPHERAL CIRCULATIONS
IN PATIENTS WITH TYPE 2 DIABETES
A. Kizu, H. Koyama, S. Tanaka, T. Maeno, M. Komatsu,
M. Emoto, H. Yokoyama, T. Shoji,
M. Inaba, Y. Nishizawa, Japan |
COMPARISON
OF THREE DIFFERENT GUIDELINES FOR TREATMENT OF DYSLIPIDEMIA
IN TYPE 2 DIABETIC PATIENTS
A. Torri, A. Branchi, D. Sommariva, Italy |
THE CORONARY HEART DISEASE RISK IN NEWLY DIAGNOSED TYPE
2 DIABETIC PERSONS
N.D. Hancu, Romania |
INSULIN
RESISTANCE IN NONALCOHOLIC FATTY LIVER DISEASE
A. Brea, D. Mosquera, E. Martin, A. Arizti, M.J.
Palomo, Spain |
EFFECTS
OF ATORVASTATIN 10 MG ON TRIGLYCERIDES IN DIABETICS TYPE
2 PATIENTS, A DOUBLE BLIND RANDOMIZED PLACEBO CONTROLLED
STUDY
B. Chanu, C. Koch, J.J. Portal, H. Laouenan, France
|
INFLUENCE
OF BIRTH WEIGHT ON THE APO E GENETIC DETERMINANTS OF PLASMA
LIPID LEVELS IN CHILDREN
C. Garces, M. Benavente, H. Ortega, E. Viturro,
B. Cano, M.A. Lasuncion,
F. Rodriguez Artalejo, M. De Oya, Spain |
ARTERIAL
STIFFNESS IN PATIENTS WITH DIABETIC NEPHROPATHY. COMPARISON
AMONG DIFFERENT ARTERIAL SEGMENTS
E. Kimoto, T. Shoji, K. Shinohara, M. Komatsu,
A. Tanaka, S. Fujiwara, H. Koyama, M. Emoto,
Y. Nishizawa, Japan |
IMPAIRED
FASTING GLUCOSE AND MYOCARDIAL INFARCTION
Z.R. Rasic-Milutinovic, B. Pencic, Z. Gluvic, N.
Milic,Yugoslavia |
B-MODE
ULTRASOUND ARTERIAL WALL THICKNESS MEASUREMENTS IN CHILDREN
MOLECULARLY PROVEN HETEROZYGOUS FOR FAMILIAL HYPERCHOLESTEROLEMIA
AND THEIR UNAFFECTED SIBLINGS
A. Wiegman, J. Rodenburg, J. Gort, W. Stok, J.
Defesche, J. Kastelein, E. De Groot,
The Netherlands |
LOWER-LIMB
PULSE WAVE VELOCITY IN DIABETIC PATIENTS WITH PERIPHERAL
ARTERIAL DISEASE
H. Yokoyama, T. Shoji, E. Kimoto, K. Shinohara,
H. Koyama, M. Emoto, Y. Nishizawa, Japan |
INSULIN
RESISTANCE AS A MARKER OF SMALL DENSE LDL IN KOREANS
H.K. Cho, G.J. Shin, S.H. Park, Y. Jang, E.Y. Cho,
D.J. Kim, S.P. Day, C.J. Packard,
J. Shepherd, M.J. Caslake, Korea, UK |
IMPACT
OF FLUVASTATIN SLOW-RELEASE ON LOW-DENSITY LIPOPROTEIN
SUBFRACTIONS IN PATIENTS WITH TYPE 2 DIABETES: BASELINE
LOW-DENSITY LIPOPROTEIN PROFILE DETERMINES SPECIFIC MODE
OF ACTION
K. Winkler, M.M. Hoffmann, I. Friedrich, R. Glaeser,
C. Abletshauser, M.W. Baumstark,
H. Wieland, W. Maerz, Germany |
DIABETES
AND INFLAMMATION GENOTYPES IN UNSTABLE ANGINA
L. Lopez, M. Irurita, A. Loma-Ossorio, A. Canas,
A. Castaneda, J. Irurita, P. Saavedra,
C. Deniz, F.J. Rodriguez, R. Chirino, F. Aros, A. Sanchez,
M. Iriarte, J. Ordovas,
K. Lindpaintner, Spain, USA |
INSULIN
AND OTHER ATHEROSCLEROTIC RISK FACTORS IN A PORTUGUESE
POPULATION AT CARDIOVASCULAR RISK
L.L. Faleiro, M.C. Martins, M.O. Rodrigues, M.T.
Seixas, A.E. Fonseca, Portugal |
HOW
AND WHICH WAY DOES MONOTHERAPY WITH ENALAPRIL DECREASE
GLOBAL CORONARY RISK IN INSULIN RESISTANCE SYNDROME PATIENTS
M.N. Mamedov, O.V. Kosmatova, L.A. Khadipash, R.G.
Oganov, Russia |
EFFECT
OF LYCOPENE AT HEMOSTASIS SYSTEM OF WOMEN WITH DIABETES
MELLITUS
M.V. Ilina, A.M. Olferiev, N.V. Berzak, A.H. Stecenco,
V.M. Shamarin, A.B. Kapitanov, Russia |
THE
E-SELECTIN S128R POLYMORPHISM IS NOT A RISK FACTOR FOR
CORONARY ARTERY DISEASE IN PATIENTS SUFFERING FROM DIABETES
MELLITUS
M. Exner, G. Endler, R. Sunder-Plassmann, M. Raith,
K. Huber, R. Marculescu,
C. Mannhgalter, O. Wagner, Austria |
RISK
FACTORS OF ATHEROSCLEROSIS IN CHILDREN
A. Efthimiadis, E. Lefkou, D. Psirropoulos, A.
Tsapas, V. Ioannidou, G. Kazinakis, N. Lefkos, Greece
|
ACCURACY
OF CARDIOVASCULAR RISK ESTIMATION IN PATIENTS WITHOUT
DIABETES
P.J. Twomey, A.S. Wierzbicki, T.M. Reynolds, UK
|
THE
DIAGNOSIS (OR NON DIAGNOSIS) OF DIABETES MELLITUS
P.J. Twomey, UK |
THE
EFFECT OF 7-YEAR INFANCY-ONSET DIETARY INTERVENTION ON
SERUM LDL AND HDL CHOLESTEROL SUBCLASSES IN HEALTHY CHILDREN:
THE PROSPECTIVE, RANDOMISED STRIP STUDY
T. Kaitosaari, T. Rönnemaa, S. Talvia, J.
Viikari, O. Simell, Finland |
PIOGLITAZONE
IMPROVES PERIPHERAL ARTERY STIFFNESS IN PATIENTS WITH
TYPE 2 DIABETES
T. Shoji, K. Shinohara, M. Komatsu, S. Fujiwara,
T. Maeno, E. Kimoto, H. Koyama, M. Emoto,
Y. Nishizawa, Japan |
ANTIOXIDANT
STATUS IN PATIENTS WITH DIABETIC RETINOPATHY
T.M. Francuz, A. Telega, A. Wojcik, B. Posielezna,
J.G. Gminski, K. Siemianowicz, Poland |
SVCAM-1,
SICAM-1 AND VWF FACTOR IN PATIENTS WITH DIABETIC RETINOPATHY
T.M. Francuz, A. Telega, M. Syzdol, K. Siemianowicz,
J.G. Gminski, Poland |
ATORVASTATIN
AND MICRONIZED FENOFIBRATE, ALONE AND IN COMBINATION,
IN TYPE-2 DIABETES MELLITUS WITH COMBINED HYPERLIPIDEMIA
V.G. Athyros, A.A. Papageorgiou, V.V. Athyrou,
D.S. Dimitriadis, A.G. Kontopoulos, Greece |
EFFECT
OF ATORVASTATIN ON LDL PARTICLES' DISTRIBUTION IN PATIENTS
WITH DYSLIPIDEMIAS OF TYPE IIA AND IIB
V. Tsimihodimos, A. Tambaki, E. Bairaktari, G.
Miltiadous, C. Seferiades, A. Tselepis,
M. Elisaf, Greece |
ATORVASTATIN THERAPY OF HYPERCHOLESTEROLEMIA IN DIABETICSS-
MORE THAN ONE BENEFIT
R. Kocic, D. Pavlovic, G. Kocic, Yugoslavia |
INFLUENCE
OF GLUCOSE CONTROL ON THE MAIN PARAMETERS OF SERUM LIPID
PROFILE AND PLATELET MEMBRANES IN PATIENTS WITH METABOLIC
SYNDROME AND TYPE 2 DIABETES MELLITUS
I.V. Medvedeva, T.A. Pugacheva, E.F. Dorodneva,
Russia |
THE
INFLUENCE OF SODIUM MONOKETOCHOLATE ON HYPOLIPIDEMIC EFFECTS
OF LOVASTATIN IN HEALTHY AND DIABETIC RATS
S. Kojic-Damjanov, M. Djeric, M. Mikov, Yugoslavia
|
CLINICAL EVALUATION OF CEREBRO VASCULAR ACCIDENT WITH
DIABETES MELLITUS TYPE 2
L. Necheska, M. Necheski, Macedonia |
THE
ACUTE EFFECTS OF INSULIN ON CHYLOMICRON METABOLISM IN
VITRO
E.M. Allister, S. Pal, J.C.L. Mamo, Australia |
Apo
B - 100 - DEFECT IN PEDIATRIC PATIENTS IN AUSTRIA: LABORATORY
AND CLINICAL DATA
N. Hachemian, V. Kretzer, B. Schmidt, G. Kostner,
K. Widhalm, Austria |
CARDIOVASCULAR
RISK FACTORS IN TYPE 2 DIABETICS: ROLE OF HYPERTENSION
AND FIBRINOGEN
P. Lazzari, A. Cappellini, Italy |
PROSPECTIVE
EVALUATION OF DIABETIC ISCHAEMIC HEART DISEASE BY COMPUTED
TOMOGRAPHY: THE PREDICT STUDY
R.S. Elkeles, M. Flather, M.D. Feher, I. Godsland,
W. Richmond, S.E. Humphries,
M.B. Rubens, S.R. Underwood, UK |
|
CUTANEOUS
VASOMOTOR RESPONSE IN DIABETICS WITH AND WITHOUT ATHEROSCLEROSIS
P. Tretjakovs, A. Lacis, A. Jurka, V. Pirags,
Latvia
|
THE
INFLUENCE OF GENETIC AND ENVIRONMENTAL FACTORS OF FIBRINOGEN
LEVEL IN TYPE 2 DIABETES
I. Tkac, J. Salagovic, M. Kozarova, I. Kalina,
Slovak Republic |
PREVALENCE
AND RISK FACTORS OF PERIPHERAL VASCULAR DISEASE IN TAIWANESE
TYPE 2 DIABETIC PATIENTS
C-H. Tseng, Taiwan |
LDL-IMMUNE
COMPLEXES IN DIABETES AND VASCULAR DISEASE
Z. Turk, M. Sesto, J. Skodlar, G. Ferencak, N.
Turk, A. Stavljenic-Rukavina, Croatia |
PARENTAL
PREDISPOSITION THE SIGNIFICANCE OF EARLY
EXPRESSION OF LOW HDL CONCENTRATION
J.I. Lapinleimu, I.O. Nuotio, J.S.A. Viikari, Finland |
| POSTER SESSION:
SYNDROME-X, sdLDL, FCHL |
STUDY
IN POPULATION WITH A HIGH PREVALENCE OF METABOLIC SYNDROME
AND FACTOR ANALYSIS OF COMPONENTS OF THE SYNDROME
A. Onat, S. Toprak, V. Sansoy, G. Hergenc, Turkey
|
EVOLUTIONARY
GENETICS, CIVILIZATION AND METABOLIC SYNDROME
I. Liberman, Russia |
LIPOPROTEIN(A)
LEVELS IN PATIENTS WITH METABOLIC SYNDROME
I.V. Medvedeva, T.A. Pugacheva, E.F. Dorodneva,
Russia |
FAMILIAL
DEFECTIVE APOLIPOPROTEIN B-100 VERSUS FAMILIAL HYPERCHOLESTEROLEMIA:
AN ASSESSMENT OF RISK
S.W. Fouchier, E.J.G. Sijbrands, J.J.P. Kastelein, J.C.
Defesche, The Netherlands |
METABOLIC
SYNDROME IN PATIENTS WITH PREMATURE ISCHEMIC HEART DISEASE
L.M. Dobordginidze, N.A. Gratsiansky, A.B. Dobrovolsky,
V.P. Masenko, M.V. Konnov, Russia |
LPL
GENE VARIANTS IN PRIMARY COMBINED HYPERLIPIDAEMIA
M. Vrablik, E. Pazourkova, R. Ceska, T. Haas, Czech
Republic |
INCREASED
APO B AND SMALL DENSE LDL IN FAMILIAL COMBINED HYPERLIPIDEMIA
ARE NOT EXPLAINED BY THE DEGREE OF INSULIN RESISTANCE
AND/OR OBESITY
M. Veerkamp, J. De Graaf, A. Stalenhoef, The Netherlands
|
SIGNIFICANCE
OF THE LEVEL OF SMALL DENSE LDL IN DIABETIC PATIENTS
M. Djeric, O. Brkljac, S. Kojic-Damanjanov, Lj.
Lepsanovic, Yugoslavia |
MOR
NECROSIS FACTOR-ALPHA RECEPTOR (sTNF-R) IN FAMILIAL COMBINED
HYPERLIPIDEMIA (FCHL)
G. Cavallo, A. Montali, L. Monetini, L. Valente,
P. Mariani, R. Cantini, T.M. Antonini,
A. Musca, R. Verna, M. Arca, Italy |
EXTRALIPID
EFFECTS OF FENOFIBRATE IN PATIENTS WITH COMBINED HYPERLIPIDEMIA
Z. Kalina, B. Okopien, L. Cwalina, D. Belowski,
A. Madej, M. Zielinski, Z.S. Herman, Poland |
| POSTER SESSION:
STATINS, SESSION-I |
STATINS REGULATE INFLAMMATORY TRANSCRIPTION FACTORS IN
HUMAN ENDOTHELIAL AND VASCULAR SMOOTH MUSCLE CELLS
W. Dichtl, J. Dulak, M. Frick, S.P. Schwarzacher,
M.P.S. Ares, J. Nilsson, O. Pachinger,
F. Weidinger, Austria, Sweden |
A
COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF ATORVASTATIN,
PRAVASTATIN, LOVASTATIN AND GEMFIBROZIL IN THE TREATMENT
OF HYPERLIPIDEMIC PATIENTS
A.I. Hatzitolios, C.F. Delivoria, C.G. Savopoulos, A.G.
Ziakas, A.D. Kounanis,
M.E. Archaniotaki, Greece |
SHORT-TERM
TREATMENT WITH ATORVASTATIN FOR PREVENTION OF CARDIAC
COMPLICATIONS AFTER VASCULAR SURGERY
B. Caramelli, A. Durazzo, D. Ikeoka, C. De Bernoche,
M. Monachini, P. Puech-Leao,
J.A.F. Ramires, Brazil |
TREATMENT
WITH ATORVASTATIN TO THE NATIONAL CHOLESTEROL EDUCATIONAL
PROGRAM GOALS VERSUS USUAL CARE IN SECONDARY CORONARY
HEART DISEASE PREVENTION. THE GREEK ATORVASTATIN ON CORONARY-HEART-DISEASE
EVALUATION (GREACE) STUDY
A.G. Athyros, A.A. Papageorgiou, B.R. Mercouris,
V.V. Athyrou, A.N. Symeonidis,
E. Basayannis, D.S. Dimitriadis, A.G. Kontopoulos, Greece
|
IS
THERE AN ESCAPE PHENOMENON ON LONG TERM STATIN TREATMENT
D. Yeshurun, O. Hochwald, D. Keren, J.E. Naschitz,
Israel |
SAFETY
OF ATORVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
AND CHRONIC HEPATITIS B
C. Petrogiannopoulos, S. Kalogeropoulos, G.S. Latsios,
G. Hartzoulakis, G. Kalogeropoulos,
A. Zaharof, Greece |
CAN
SIMVASTATIN THERAPY INFLUENCE ON MYOCARDIAL PERFUSION
IN PATIENTS WITH ISCHEMIC HEART DISEASE
V.G. Naumov, I.V. Sergienko, A.A. Lyakishev, Russia
|
HMG-CoA REDUCTASE INHIBITORS REDUCE INTIMA-MEDIA THICKNESS
AND SOLUBLE ADHESION MOLECULES PLASMA LEVELS IN HYPERCHOLESTEROLEMIC
PATIENTS
S. Fantappie', L. Grigore, F.M. Maggi, K. Garlaschelli,
S. Raselli, L. Redaelli, A.L. Catapano,
Italy |
EFFECTIVITY
OF SIMVASTATIN ON LIPID CHANGES AND THEIR MUTUAL CORRELATIONS
A. Kalvelis, G. Bahs, Latvia |
ERECTILE DYSFUNCTION AND STATIN THERAPY: INTERACTION WITH
CARDIOVASCULAR RISK FACTORS AND DRUG THERAPIES
H. Solomon, J. Man, Y.P. Samarasinghe, M.D. Feher, A.S.
Wierzbicki, G. Jackson, UK |
EFFECT OF ROSUVASTATIN ON LDL-CHOLESTEROL, MEVALONIC ACID
AND OTHER LIPID MEASUREMENTS IN PATIENTS WITH HOMOZYGOUS
FAMILIAL HYPERCHOLESTEROLAEMIA
D. Marais, F. Raal, E. Stein, D. Rader, K. Smith,
J. Blasetto, W. Wilpshaar, South Africa,
USA, UK |
EFFECT
OF SIMVASTATIN AND ITS ASSOCIATION WITH L-ARGININE AND
ALFA-TOCOPHEROL ON ASYMMETRICAL DIMETHYLARGININE AND NITRIC
OXIDE METABOLITES
E.C.Pereira , M.C. Bertolami, A.A. Faludi, D.S.P.
Abdalla, Brazil |
EFFECTS
OF ROSUVASTATIN ALONE AND COMBINED WITH EXTENDED-RELEASE
NIACIN ON APO B- AND APO A-CONTAINING LIPOPROTEINS AND
TRIGLYCERIDES IN ATHEROGENIC DYSLIPIDEMIA
D.M. Capuzzi, J.M. Morgan, R. Weiss, R.R. Chitra,
M.D. Cressman, H.G. Hutchinson, USA |
ATORVASTATIN
AND PRAVASTATIN IN NON ST ELEVATION ACUTE CORONARY SYNDROME.
EFFECT ON PLATELET AGGREGATION AND MARKERS OF INLAMMATION
E.V. Pokrovskaya, N.A. Vaulin, N.A. Gratsiansky,
O.V. Averkov, A.D. Deev, Russia |
COADMINISTRATION
OF EZETIMIBE PLUS ATORVASTATIN
E. Stein, S. Stender, P. Mata, D. Ponsonnet, L.
Melani, L. Lipka, R. Suresh, E. Veltri,
USA, Denmark, Spain |
FOURTEENS YEARS EXPERIENCE OF THE STATINS APPLICATION
FOR THE PATIENTS WITH PRIMARY HYPERCHOLESTEROLAEMIA
G.A. Konovalov, P.V. Zvezdkin, A.A. Vinnikova,
T.S. Kurganskaya, N.K. Golubeva, Russia |
DIFFERENTIAL
REGULATION OF LIPOPROTEIN METABOLISM BY ATORVASTATIN AND
FENOFIBRATE
G.F. Watts, H.R. Barrett, A.P. Serone, D.C. Chan,
J. Ji, K.D. Croft, A.J. Johnson, Australia, USA |
EFFICACY
OF FLUVASTATIN TOGETHER WITH FENOFIBRATE IN HYPERCHOLESTEROLEMIC,
TYPE 2 DIABETIC SUBJECTS COMPARED TO MONOTHERAPY
G. Derosa, A. Mugellini, L. Ciccarelli, G. Crescenzi,
M. Ghelfi, R. Fogari, Italy |
REDUCTION
IN ULTRA-SENSITIVE C-REACTIVE PROTEIN LEVELS AND REGRESSION
OF INTIMA MEDIA THICKNESS WITH HIGH AND LOW DOSES ATORVASTATIN
IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLAEMIA
H. Nawawi, N. Mahmud, S. Muid, N.S. Osman, B.A.K.
Khalid, K. Yusoff, Malaysia |
COMPARISON
OF THE LIPID LOWERING EFFECTS OF SIMVASTATIN AND ATORVASTATIN
G. Paragh, I. Seres, D. Torocsik, L. Illyes, Z.
Szilvassy, P. Kovacs, Hungary |
APOE
POLYMORPHISM MODULATES TRIGLYCERIDE LEEVLS IN FDB PATIENTS
AFTER STATIN THERAPY. AN EXAMPLE OF GENE-GENE INTERACTION
M. Vrablik, A. Horinek, E. Pazourkova, R. Ceska,
T. Haas, Czech Republic |
| POSTER SESSION:
VARIA |
CAPILLARY
ISOTACHOPHORESIS STUDY OF HYPERTRIGLYCERIDEMIA-INDUCED
CHANGES IN CHARGE PROFILE OF HUMAN PLASMA LIPOPROTEINS
A.D. Dergunov, A. Hoy, S. Visvikis, G. Siest, Russia,
France |
INTERACTIONS
BETWEEN EXCHANGEABLE APOLIPOPROTEINS IN SOLUTION AND IN
LIPID-BOUND FORM
A.D. Dergunov, S. Visvikis, G. Siest, Russia, France
|
FETAL
THERAPY INFLUENCE OF THE HEMORHEOLOGIC PARAMETERS
M. Tatarinov, L. Koryakina, V. Marchenko, A. Runovich,
Russia |
FETAL
THERAPY IN THE CORRECTION OF LIVER METABOLIC FUNCTION
IN ISCHEMIC PATIENTS
E. Kuznetsova, V. Gorohova, A. Gorohov, T. Kurilskaya,
S. Nikiforov, A. Runovich, Russia |
CHANGES
IN THE METABOLIC STATUS IN ISCHEMIC PATIENTS
V. Gorohova, E. Kuznetsova, A. Gorohov, A. Runovich,
Russia |
FETAL
THERAPY EFFECT ON THE HEMOSTASIS CORRECTION
L. Koryakina, V. Marchenko, L. Zubareva, A. Runovich,
Russia |
CORRELATION
OF LDL PARTICLE SIZE WITH PLASMA LIPOPROTEINS IN HEALTHY
MACEDONIAS
B.B. Todorova, S.B. Alabakovska, Macedonia |
OLEIC,
LINOLEIC AND ALPHA-LINOLENIC ACIDS FROM COMBINED VEGETABLE
OILS: WHERE ARE THE LIMITS FOR BENEFICIAL EFFECTS ON LIPEMIA
IN HUMANS?
B. Delplanque, F. Mendy, B. Le Roy, E. Fenart,
P. Boulos, N. Combe, A. Thaminy, F. Syeda,
A. Ruelland, France |
CARDIOVASCULAR
RISK IN NONALCOHOLIC FATTY LIVER DISEASE
A. Brea, D. Mosquera, E. Martin, A. Arizti, M.J.
Palomo, Spain |
ANNEALING
TEMPERATURE OF POLYMERASE CHAIN REACTION IS IMPORTANT
FOR THE DETECTION OF HETEROZYGOUS GENE MUTATIONS
A. Takagi, Y. Ikeda, A. Yamamoto, Japan |
IDENTIFICATION
OF THE PROTEOGLYCAN BINDING SITE IN APOLIPOPROTEIN B48
C. Flood, M. Gustafsson, J. Boren, Sweden |
EFFECT
OF CHOLATE ON CHOLESTEROL CONCENTRATION AND HEPATIC TISSUE
IN APOLIPOPROTEIN E DEFICIENT MICE
D. Bobkova, R. Poledne, Czech Republic |
EFFECTS
OF VARIOUS FIBRATES ON SERUM ALKALINE PHOSPHATASE ACTIVITY
E. Ganotakis, V. Tsimihodimos, E. Rizos, H. Milionis,
V. Athyros, E. Bairaktari,
C. Seferiades, M. Elisaf, Greece |
SERUM
LIPID ABNORMALITIES IN PATIENTS WITH ACUTE MYOCARDIAL
INFARCTION
D. Papakonstantinou, E. Alexopoulos, G. Vrentzos, J.A.
Papadakis, E. Ganotakis, Greece |
QUALITY
OF LIFE, ANXIETY AND CONCERNS OF CHILDREN WITH FAMILIAL
HYPERCHOLESTEROLEMIA AND THEIR PARENTS
S. De Jongh, M.C. Kerckhoffs, M.A. Grootenhuis,
B.F. Last, H.D. Bakker, The Netherlands |
ATAZANAVIR:
AN HIV PROTEASE INHIBITOR (PI) THAT DOES NOT CAUSE ATHEROGENIC
LIPOPROTEIN CHANGES
P. Slade, P. Piliero, P. Cahn, G. Pantaleo, J.
Gatell, K. Squires, L. Percival, I. Sanne,
R. Wood, P. Phanuphak, S. Shelton, A. Lazzarin, A. Thiry,
T. Kelleher, M. Giordano,
S. Schnittman, Spain, USA, Argentina, Switzerland, Belgium,
South Africa, Thailand |
PHYSICAL
ACTIVITY MODULATES THE EFFECT OF APOE GENOTYPE ON HDL-CHOLESTEROL
CONCENTRATIONS IN A SPANISH POPULATION
D. Corella, M. Guillen, D. Godoy, J.V. Sorli, O.
Portoles, C. Saiz, O. Cortelli, J.M. Ordovas,
Spain, USA |
HOMOCYSTEINEMIA
AND CORONARIAN RISK
C. Belizna, M.A. Pistorius, B. Planchon, France |
LIMB
ISCHAEMIA AND LEUKAEMIA
C. Belizna, M.A. Pistorius, B. Planchon, France |
THE
MECHANISM OF INTRAVASCULAR TRANSFER OF LIPIDS: INTRALIPID
INFUSION IN NORMAL AND PARENTERALLY FED-PATIENTS
P.N. Demacker, M.P. Hectors, A.J. Naber, The Netherlands |
THE
SCAVENGER RECEPTOR CYSTEINE RICH (SRCR) DOMAIN OF HUMAN
MACROPHAGE SCAVENGER RECEPTOR A1 IS INVOLVED IN CHEMOTAXIS
H. Heider, M. Dobler, M. Hellsten, Switzerland |
EVALUATION
OF AN IMMUNOTURBIDIMETRIC ASSAY FOR THE DETERMINATION
OF APOLIPOPROTEIN B SERUM LEVELS. COMPARATIVE ANALYSIS
WITH A NEPHELOMETRIC METHOD
A. Gavarro, E. Berlanga, F. Campos, F. Salceda,
R. Ustrell, M. Torra, Spain |
INFLUENCE
OF GENDER AND AGE ON CHYLOMICRON METABOLISM
C.G.C. Vinagre, A.T. Morikawa, L.I.V. Brandizzi,
E. Ficker, R.C. Maranhão, Brazil |
REMOVAL
FROM THE PLASMA OF A CHOLESTEROL-RICH EMULSION IN HEART
TRANSPLANTATION PATIENTS
C.G. Puk, C.C.G. Vinagre, E. Bocchi, F. Bacal,
R. Barbosa, J.A. Ramires,
R.C. Maranhão, Brazil |
| POSTER SESSION:
RISK FACTORS, ATHEROSCLEROSIS AND MI |
ATHEROSCLEROTIC
LESIONS OF MAJOR HEAD ARTERIES: AGE PECULIARITIES
S.M. Kuznetsova, V.A. Rogozhin, I.I. Glazovskaya,
Ukraine |
PREDISPOSING
FACTORS IN 100 PATIENTS WITH SILENT MYOCARDIAL INFARCTION
M.J. Mahmoudi, M. Gharouni, S. Moradmand, N. Rezaei,
M. Mahmoudi, S. Dargahi, Iran |
NOVEL
FINDINGS OF CORONARY COMPENSATORY ENLARGEMENT OF WHHL
RABBITS BY A NEWLY DEVELOPED ANALYSIS
M. Shiomi, T. Ito, K. Yoshida, M. Hasegawa, Japan
|
HIPOKINESIA
AS A RISK FACTOR FOR ATHEROSCLEROSIS
V.P. Hakobyan, K.V. Melkonyan, Armenia |
PROGNOSTIC VALUE OF DYSLIPOPROTEINEMIAS AT CEREBRAL BLOOD
CIRCULATION DISTURBANCES IN ELDERLY PEOPLE ACCORDING TO
LONG-TERM OBSERVATION DATA
S.N. Novikova, Ukraine |
HYPERTRIGLYCERIDEMIA:
A SECONDARY TARGET FOR PRIMARY PREVENTION (ATP III)
H. Slater, E. Parafioriti, A. Tortora, S. Ilutovich,
Argentina |
INDIVIDUAL
RISK FACTOR VARIATION WITH TIME PREDICTS CLINICAL CORONARY
HEART DISEASE
I.F. Godsland, Z. Efstathiadou, J.A.R. Jeffs, D.G.
Johnston, UK |
CHARACTERIZATION
OF PRE-BETA- AND ALPHA-MIGRATING HDL SUBFRACTIONS IN RUSSIAN
MEN WITH HIGH AND LOW HDL CHOLESTEROL LEVEL
A.P. Serdyuk, V.A. Metelskaya, C. Lasselin, G.R.
Castro, Russia, France |
MORBIDITY
AND MORTALITY IN ELDERLY WITH LOW TOTAL SERUM CHOLESTEROL
A.K. Zacharof, C. Petrogiannopoulos, C. Flevaris,
G. Karachalios, Greece |
SAFETY
AND EFFICACY OF FENOFIBRATE FOR THE TREATMENT OF DYSLIPIDEMIA
IN AIDS
B. Caramelli, C.Y.S.M. De Bernoche, A.M.C. Sartori,
T.M.V. Strabelli, M. Monachini,
R. Santos, D. Uip, Brazil |
APOLIPOPROTEIN
E POLYMORPHISM AND CAROTID ATHEROSCLEROSIS IN PATIENTS
WITH CORONARY DISEASE
C. Fernandez-Miranda, J.L. Aranda, M.A. Martin,
J. Arenas, V. Nunez,
A. Gomez De La Camara, Spain |
USE
OF DIFFERENT CUT-OFF VALUES TO STUDY THE POWER OF CARDIAC
TROPONIN I IN PREDICTING CLINICAL OUTCOME AFTER ELECTIVE
UNCOMPLICATED PERCUTANEOUS CORONARY INTERVENTION
S.M. Saadeddin, M.A. Habbab, S.H. Sobki, G.A. Ferns,
UK |
LONG
TERM EFFICACY OF LOW FAT LOW CHOLESTEROL DIET IN THE MANAGEMENT
OF HYPERCHOLESTEROLEMIA
A. Branchi, A.M. Fiorenza, F. Muzio, A. Torri,
C. Berra, E. Colombo, E. Dalla Valle,
D. Sommariva, Italy |
CORONARY
HEART DISEASE MORTALITY DECLINE AND INFECTIOUS DISEASES
IN THE CZECH POPULATION
A. Dvorakova, R. Poledne, Czech Republic
|
SOCIAL
DIFFERENCES IN ASSOCIATION TO ESTABLISHED AND EMERGING
CARDIOVASCULAR RISK FACTORS, AT POPULATION LEVEL; THE
ATTICA STUDY
D. Panagiotakos, C. Pitsavos, J. Skoumas, C. Chrysohoou,
M. Toutouza, I. Papaioannou,
A. Zeimbekis, C. Stefanadis, P. Toutouzas, Greece |
THE
INVERSE ASSOCIATION BETWEEN EDUCATIONAL STATUS AND THE
PREVALENCE OF ESTABLISHED AND EMERGING CARDIOVASCULAR
RISK FACTORS: THE ATTICA STUDY
D. Panagiotakos, C. Pitsavos, J. Skoumas, C. Chrysohoou,
M. Toutouza, I. Papaioannou,
A. Zeimbekis, C. Stefanadis, P. Toutouzas, Greece |
LDL
DENSITY SIGNIFICANTLY PREDICTS CAROTID PLAQUE CELL COMPOSITION
AND PREVALENCE OF CEREBROVASCULAR EVENTS IN PATIENTS WITH
SEVERE CAROTID STENOSIS
A. Zambon, S. Bertocco, E. Faggin, N. Vitturi,
M. Puato, A.C. Pessina, G. Crepaldi,
P. Pauletto, Italy |
SERUM
LIPID LEVELS AND LIPID LOWERING THERAPY IN PATIENTS WITH
CORONARY ARTERY DISEASE HISTORY: HOW MUCH ATTENTION IS
BEING PAID? IS THE MANAGEMENT SUFFICIENT?
A.D. Labrou, D.K. Theodoridis, A.N. Zagoutis, S.K. Terzi,
L.F. Borgi, O.E. Koutsogiannis,
A.G. Savvopoulou, A.E. Panagiotidou, A.K. Gotsis,
Greece |
RISK
FACTORS FOR ATHEROSCLEROSIS ARE PRESENT IN PATIENTS WITH
ASYMPTOMATIC AORTIC STENOSIS
P. Das, H. Rimington, P.J. Lumb, M.A. Crook, A.S.
Wierzbicki, UK |
CARDIOVASCULAR
RISK FACTORS IN FAMILIAL HYPERCHOLESTEROLEMIA
A.C.M. Jansen, J.J.P. Kastelein, The Netherlands
|
THE
DIFFICULTY TO EVALUATE THE GLOBAL CARDIO- AND CEREBRO-VASCULAR
RISK IN FCH PATIENTS: A DIDACTIC CASE REPORT WITH EARLY
TOTAL OCCLUSION OF THE RIGHT CAROTID
A.F.G. Cicero, S. Linarello, M.P. Panourgia, S.
Nascetti, A. Gaddi, Italy |
URIC
ACID IS AN INDIPENDENT RISK FACTOR FOR CARDIOVASCULAR
DISEASE? THE BRISIGHELLA HEART STUDY
S. D'Addato, A.F.G. Cicero, A. Dormi, Z. Sangiorgi,
S. Nascetti, A. Gaddi, Italy |
CORONARY
HEART DISEASE RISK ASSESSMENT IN DIABETES MELLITUS: A
COMPARISON OF EURO 98 AND UK 99 CHARTS
A. Cerghizan, Romania |
IMPORTANCE
OF VECTORCARDIOGRAPHY FOR EVALUTION OF ISCHEMIC DISEASE
Z. Pekmezovic, M. Ristic, R. Surbat, D. Milanovic,
R. Jevtovic, M. Ilic-Milovanovic, Yugoslavia |
EFFECTS
OF CUPRESSUS SEMPERVIRENS CONE EXCTRACT ON LIPID PROFILE
IN WHISTAR RATS
S. Karkabounas, D. Kiortsis, J. Zelovitis, P. Skafida,
C. Demetzos, M. Malamas, M. Elisaf,
A. Evangelou, Greece |
TREND
RISK FACTORS IN CORONARY PREVENTION STUDY OF REPUBLIKA
SRPSKA (ROSCOPS)
D. Vulic, L. Keric, B. Vulic, M. Krneta, Z. Pavic,
Bosnia Herzegovina |
AUTONOMIC
NERVOUS SYSTEM AROUSAL AND THE FREQUENCY OF ANGINA ATTACKS
E.S.Strodl , D. Colquhoun, C. Aroney, J.
Kenardy, Australia |
DETERMINANTS
OF PRECLINICAL CAROTID AND FEMORAL ATHEROSCLEROSIS IN
PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
E. Ros, C. Rodriguez-Villar, R. Gilabert, M. Vela,
D. Zambon, R. Deulofeu, Spain |
THE
EFFECT OF PHYSICAL ACTIVITY ON LIPOPROTEIN LEVELS: THE
ATTICA EPIDEMIOLOGICAL STUDY
J. Skoumas, C. Pitsavos, C. Chrysohoou, D. Panagiotakos,
M. Toutouza, I. Papaioannou,
A. Zeimbekis, C. Stefanadis, P. Toutouzas, Greece |
PREDICTORS
FOR CARDIOVASCULAR EVENTS, IN SUBJECTS WITH FAMILIAL HYPERCHOLESTEROLEMIA:
15 YEARS FOLLOW UP (1987-2002)
J. Skoumas, C. Pitsavos, C. Chrysohoou, D. Panagiotakos,
M. Toutouza, I. Papaioannou,
A. Zeimbekis, C. Stefanadis, P. Toutouzas, Greece |
THE
EFFECT MINIMAL DOSE LIPID LOWERING THERAPY IN PATIENTS
WITH HIGH CORONARY RISK AND WITH CHD
D.B. Vulic, L. Keric, M. Krneta, M. Milanovic,
N. Mrkobrada, S. Obradovic, M. Begenisic,
Z. Pavic, Bosnia Herzegovina |
LIPIDS
AND CAROTID ATHEROSCLEROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS
(SLE) : A CASE-CONTROL STUDY
P. Valdivielso, M. Macias, M. Haro, A. Fernandez-Nebro,
J.J. Gomez-Doblas,
P. Gonzalez-Santos, Spain |
SEX
DIFFERENCES IN THE ASSOCIATION OF SERUM BILIRUBIN CONCENTRATION
WITH RISK OF CORONARY ARTERY DISEASE
A. Hamwi, G. Endler, R. Sunder-Plassmann, M. Exner,
K. Huber, C. Mannhgalter, O. Wagner, Austria |
EFFICACY
OF " EDTA" ON CORONARY ARTERY DISEASE
F. Jalali, S. Tabiban, Iran |
DO
FINGERPRINTS PREDICT ACUTE MYOCARDIAL INFARCTION?
F. Jalali, H. Tilaki, Iran |
COULD
A NUTRACEUTICAL DAILY ASSUMPTION SIGNIFICANTLY IMPROVE
THE INDIVIDUAL CARDIOVASCULAR RISK PROFILE?
A.F.G. Cicero, M.P. Panourgia, A. Fiorito, S. D’Addato,
A. Gaddi, Italy |
SEX-RELATED
DIFFERENCES IN CARDIOVASCULAR RISK FACTORS AMONG SERIOUS
DEPRESSIVE PATIENTS : PRELIMINARY RESULTS OF THE PPHSS
A.F.G. Cicero, M. Forghieri, F. Cipressi, R. Arletti,
Italy |
RISK
FACTORS AND PERIPHERIC ARTERY DISEASE PREVALANCE IN CORONARY
ARTERY DISEASE PATIENTS WHO ALSO HAVE CAROTID ARTERY DISEASE
S. Aytekin, Z. Ozyedek, V. Aytekin, E. Kabatas,
E. Rizaoglu, B. Akpinar, O. Yildirimturk,
R. Ozcan, I.C.C. Demiroglu, D-I. Demiroglu, Turkey |
TWO
MMP2 GENE PROMOTER POLYMORPHISMS IN CHRONIC HEART FAILURE
A. Vasku, M. Goldbergova, L. Spinarova, J. Spinar,
J. Toman, Czech Republic |
AN
ANGIOGRAPHIC STUDY OF RISK FACTORS FOR CORONARY HEART
DISEASE IN PAKISTAN
S. Nishtar, A.S. Wierzbicki, P.J. Lumb, M. Lambert-Hammill,
J. Gill, Pakistan, UK |
CARDIOVASCULAR
RISK AND ABSOLUTE NECESSITY OF PRYMARY PREVENTIVE INTERVENTION
IN AN ELDERLY POPULATION
I. Lopez-Rodriguez, M.P. Rodriguez-Ledo, J. Muniz
Garcia, R. Gabriel Sanchez,
I.L. Alvarez-Choren, J.M. Paz Carreira, J.A. Mendez Fernandez,
M.D. Montiel Carracedo,
J.M. Rabade Cacharron, M.J. Garza Vazquez, A. Lopez Quintela,
Spain |
ARTERIAL
WALL ELASTICITY AMONG MALE AND FEMALE NON-SMOKERS AND
SMOKERS
H. Marcoyannopoulou-Fojas, N. Papageorgakis, G.M.
Fojas, G. Jullien, Greece |
LIPID
PARAMETERS IN ELDERLY PATIENTS SUFFERING FIRST ACUTE ISCHEMIC
STROKE
H. Milionis, E. Liberopoulos, G. Miltiadous, C.
Tzallas, E. Bairaktari, M. Elisaf, Greece |
CAROTID
AND FEMORAL INTIMA-MEDIA THICKNESS IN NORMOTENSIVE ADULT
PATIENTS SUCCESFULLY OPERATED FOR AORTIC COARCTATION
J. Vriend, E. De Groot, J. Kastelein, B. Mulder,
H. Vliegen, G. Veen, W. Stok, D. Samson,
The Netherlands |
THE
CAROTID INTIMA-MEDIAL THICKNESS AS A MARKER OF SEVERE
CORONARY ARTERY DISEASE
E. Izcovich, V. Daru, E. Salmon, S. Baratta, R.
Iglesias, M. Gonzalez, A. Sosa Liprandi,
Argentina |
CHARACTERIZATION
OF THE PORTUGUESE POPULATION WITH HIGH AND VERY HIGH CARDIOVASCULAR
RISK AND PREVIOUS ACUTE MYOCARDIAL INFARCTION ATTENDING
PRIMARY CARE PHYSICIAN: SUB STUDY ALTOMAR - AMI ALTOMAR
TRIAL - ALTO E MUITO ALTO RISCO CARDIOVASCULAR
A. Pinto, L. Negrao, M. Carrageta, Portugal |
|
| | |
